{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:45:06Z","timestamp":1782409506398,"version":"3.54.5"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,7,12]],"date-time":"2012-07-12T00:00:00Z","timestamp":1342051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,7,12]],"date-time":"2012-07-12T00:00:00Z","timestamp":1342051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1038\/jhh.2012.27","type":"journal-article","created":{"date-parts":[[2012,7,12]],"date-time":"2012-07-12T09:33:58Z","timestamp":1342085638000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Salt, aldosterone and hypertension"],"prefix":"10.1038","volume":"27","author":[{"given":"E","family":"Pimenta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R D","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Stowasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,12]]},"reference":[{"issue":"10","key":"BFjhh201227_CR1","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1161\/CIR.0b013e31820d0793","volume":"123","author":"LJ Appel","year":"2011","unstructured":"Appel LJ, Frohlich ED, Hall JE, Pearson TA, Sacco RL, Seals DR et al. The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association. Circulation 2011; 123 (10): 1138\u20131143.","journal-title":"Circulation"},{"issue":"17","key":"BFjhh201227_CR2","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1001\/jama.2011.574","volume":"305","author":"K Stolarz-Skrzypek","year":"2011","unstructured":"Stolarz-Skrzypek K, Kuznetsova T, Thijs L, Tikhonoff V, Seidlerova J, Richart T et al. Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA 2011; 305 (17): 1777\u20131785.","journal-title":"JAMA"},{"issue":"8","key":"BFjhh201227_CR3","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/ajh.2011.115","volume":"24","author":"RS Taylor","year":"2011","unstructured":"Taylor RS, Ashton KE, Moxham T, Hooper L, Ebrahim S . Reduced dietary salt for the prevention of cardiovascular disease: a meta-analysis of randomized controlled trials (Cochrane Review). Am J Hypertens 2011; 24 (8): 843\u2013853.","journal-title":"Am J Hypertens"},{"issue":"3","key":"BFjhh201227_CR4","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1210\/jc.2003-031337","volume":"89","author":"P Mulatero","year":"2004","unstructured":"Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 2004; 89 (3): 1045\u20131050.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"BFjhh201227_CR5","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1210\/jc.2008-0104","volume":"93","author":"JW Funder","year":"2008","unstructured":"Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008; 93 (9): 3266\u20133281.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8812","key":"BFjhh201227_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0140-6736(92)93225-C","volume":"340","author":"RD Gordon","year":"1992","unstructured":"Gordon RD, Klemm SA, Tunny TJ, Stowasser M . Primary aldosteronism: hypertension with a genetic basis. Lancet 1992; 340 (8812): 159\u2013161.","journal-title":"Lancet"},{"issue":"13","key":"BFjhh201227_CR7","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1001\/jama.1977.03270400035014","volume":"237","author":"CE Grim","year":"1977","unstructured":"Grim CE, Weinberger MH, Higgins JT, Kramer NJ . Diagnosis of secondary forms of hypertension. A comprehensive protocol. JAMA 1977; 237 (13): 1331\u20131335.","journal-title":"JAMA"},{"issue":"3","key":"BFjhh201227_CR8","doi-asserted-by":"publisher","first-page":"386","DOI":"10.7326\/0003-4819-90-3-386","volume":"90","author":"MH Weinberger","year":"1979","unstructured":"Weinberger MH, Grim CE, Hollifield JW, Kem DC, Ganguly A, Kramer NJ et al. Primary aldosteronism: diagnosis, localization, and treatment. Ann Intern Med. 1979; 90 (3): 386\u2013395.","journal-title":"Ann Intern Med."},{"issue":"18","key":"BFjhh201227_CR9","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1001\/archinte.1993.00410180075008","volume":"153","author":"MH Weinberger","year":"1993","unstructured":"Weinberger MH, Fineberg NS . The diagnosis of primary aldosteronism and separation of two major subtypes. Arch Intern Med 1993; 153 (18): 2125\u20132129.","journal-title":"Arch Intern Med"},{"issue":"10","key":"BFjhh201227_CR10","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.1210\/jc.2009-1399","volume":"94","author":"M Stowasser","year":"2009","unstructured":"Stowasser M . Update in primary aldosteronism. J Clin Endocrinol Metab 2009; 94 (10): 3623\u20133630.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"BFjhh201227_CR11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","volume":"42","author":"L Mosso","year":"2003","unstructured":"Mosso L, Carvajal C, Gonzalez A, Barraza A, Avila F, Montero J et al. Primary aldosteronism and hypertensive disease. Hypertension 2003; 42 (2): 161\u2013165.","journal-title":"Hypertension"},{"issue":"6","key":"BFjhh201227_CR12","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1161\/HYPERTENSIONAHA.108.189141","volume":"51","author":"DA Calhoun","year":"2008","unstructured":"Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008; 51 (6): 1403\u20131419.","journal-title":"Hypertension"},{"issue":"11 Part 1","key":"BFjhh201227_CR13","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S0895-7061(03)01032-X","volume":"16","author":"MK Nishizaka","year":"2003","unstructured":"Nishizaka MK, Zaman MA, Calhoun DA . Efficacy of low-dose spironolactone in subjects with resistant hypertension. Am J Hypertens 2003; 16 (11 Part 1): 925\u2013930.","journal-title":"Am J Hypertens"},{"issue":"11","key":"BFjhh201227_CR14","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1001\/archinte.168.11.1159","volume":"168","author":"KK Gaddam","year":"2008","unstructured":"Gaddam KK, Nishizaka MK, Pratt-Ubunama MN, Pimenta E, Aban I, Oparil S et al. Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion. Arch Intern Med 2008; 168 (11): 1159\u20131164.","journal-title":"Arch Intern Med"},{"issue":"8","key":"BFjhh201227_CR15","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"P Milliez","year":"2005","unstructured":"Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ . Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005; 45 (8): 1243\u20131248.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"BFjhh201227_CR16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","volume":"168","author":"C Catena","year":"2008","unstructured":"Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R et al. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med 2008; 168 (1): 80\u201385.","journal-title":"Arch Intern Med"},{"issue":"14","key":"BFjhh201227_CR17","doi-asserted-by":"publisher","first-page":"1G","DOI":"10.1016\/0002-9149(90)90952-W","volume":"65","author":"KT Weber","year":"1990","unstructured":"Weber KT, Janicki JS, Pick R, Capasso J, Anversa P . Myocardial fibrosis and pathologic hypertrophy in the rat with renovascular hypertension. Am J Cardiol 1990; 65 (14): 1G\u20137G.","journal-title":"Am J Cardiol"},{"issue":"5","key":"BFjhh201227_CR18","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1006\/jmcc.1993.1066","volume":"25","author":"CG Brilla","year":"1993","unstructured":"Brilla CG, Matsubara LS, Weber KT . Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. J Mol Cell Cardiol 1993; 25 (5): 563\u2013575.","journal-title":"J Mol Cell Cardiol"},{"issue":"5","key":"BFjhh201227_CR19","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1161\/01.CIR.82.5.1730","volume":"82","author":"K Swedberg","year":"1990","unstructured":"Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L . Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation 1990; 82 (5): 1730\u20131736.","journal-title":"Circulation"},{"issue":"10","key":"BFjhh201227_CR20","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999; 341 (10): 709\u2013717.","journal-title":"N Engl J Med"},{"issue":"14","key":"BFjhh201227_CR21","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003; 348 (14): 1309\u20131321.","journal-title":"N Engl J Med"},{"issue":"5","key":"BFjhh201227_CR22","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.107.095448","volume":"50","author":"C Catena","year":"2007","unstructured":"Catena C, Colussi G, Lapenna R, Nadalini E, Chiuch A, Gianfagna P et al. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension 2007; 50 (5): 911\u2013918.","journal-title":"Hypertension"},{"issue":"6","key":"BFjhh201227_CR23","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1161\/01.CIR.95.6.1471","volume":"95","author":"GP Rossi","year":"1997","unstructured":"Rossi GP, Sacchetto A, Pavan E, Palatini P, Graniero GR, Canali C et al. Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma. Circulation 1997; 95 (6): 1471\u20131478.","journal-title":"Circulation"},{"issue":"9","key":"BFjhh201227_CR24","doi-asserted-by":"publisher","first-page":"5070","DOI":"10.1210\/jc.2005-0681","volume":"90","author":"M Stowasser","year":"2005","unstructured":"Stowasser M, Sharman J, Leano R, Gordon RD, Ward G, Cowley D et al. Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. J Clin Endocrinol Metab 2005; 90 (9): 5070\u20135076.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"BFjhh201227_CR25","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1172\/JCI118867","volume":"98","author":"EL Greene","year":"1996","unstructured":"Greene EL, Kren S, Hostetter TH . Role of aldosterone in the remnant kidney model in the rat. J Clin Invest 1996; 98 (4): 1063\u20131068.","journal-title":"J Clin Invest"},{"issue":"1 Part 2","key":"BFjhh201227_CR26","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1161\/01.HYP.31.1.451","volume":"31","author":"R Rocha","year":"1998","unstructured":"Rocha R, Chander PN, Khanna K, Zuckerman A, Stier CT . Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats. Hypertension 1998; 31 (1 Part 2): 451\u2013458.","journal-title":"Hypertension"},{"issue":"2","key":"BFjhh201227_CR27","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G et al. Renal damage in primary aldosteronism: results of the PAPY Study. Hypertension 2006; 48 (2): 232\u2013238.","journal-title":"Hypertension"},{"issue":"22","key":"BFjhh201227_CR28","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1001\/jama.295.22.2638","volume":"295","author":"LA Sechi","year":"2006","unstructured":"Sechi LA, Novello M, Lapenna R, Baroselli S, Nadalini E, Colussi GL et al. Long-term renal outcomes in patients with primary aldosteronism. JAMA 2006; 295 (22): 2638\u20132645.","journal-title":"JAMA"},{"issue":"6644","key":"BFjhh201227_CR29","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1136\/bmj.297.6644.319","volume":"297","author":"Intersalt Cooperative Research Group","year":"1988","unstructured":"Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24\u2009h urinary sodium and potassium excretion. BMJ 1988; 297 (6644): 319\u2013328.","journal-title":"BMJ"},{"issue":"11","key":"BFjhh201227_CR30","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/sj.jhh.1001459","volume":"16","author":"FJ He","year":"2002","unstructured":"He FJ, MacGregor GA . Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens 2002; 16 (11): 761\u2013770.","journal-title":"J Hum Hypertens"},{"issue":"3","key":"BFjhh201227_CR31","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1161\/HYPERTENSIONAHA.109.131235","volume":"54","author":"E Pimenta","year":"2009","unstructured":"Pimenta E, Gaddam KK, Oparil S, Aban I, Husain S, Dell\u2019Italia LJ et al. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension 2009; 54 (3): 475\u2013481.","journal-title":"Hypertension"},{"issue":"6","key":"BFjhh201227_CR32","first-page":"893","volume":"120","author":"CG Brilla","year":"1992","unstructured":"Brilla CG, Weber KT . Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. J Lab Clin Med 1992; 120 (6): 893\u2013901.","journal-title":"J Lab Clin Med"},{"issue":"10","key":"BFjhh201227_CR33","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1210\/endo.141.10.7711","volume":"141","author":"R Rocha","year":"2000","unstructured":"Rocha R, Stier CT, Kifor I, Ochoa-Maya MR, Rennke HG, Williams GH et al. Aldosterone: a mediator of myocardial necrosis and renal arteriopathy. Endocrinology 2000; 141 (10): 3871\u20133878.","journal-title":"Endocrinology"},{"issue":"2","key":"BFjhh201227_CR34","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.mce.2011.09.008","volume":"350","author":"MJ Young","year":"2012","unstructured":"Young MJ, Rickard AJ . Mechanisms of mineralocorticoid salt-induced hypertension and cardiac fibrosis. Mol Cell Endocrinol 2012; 350 (2): 248\u2013255.","journal-title":"Mol Cell Endocrinol"},{"issue":"11","key":"BFjhh201227_CR35","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1038\/sj.ki.5000378","volume":"69","author":"CS Fox","year":"2006","unstructured":"Fox CS, Larson MG, Hwang SJ, Leip EP, Rifai N, Levy D et al. Cross-sectional relations of serum aldosterone and urine sodium excretion to urinary albumin excretion in a community-based sample. Kidney Int 2006; 69 (11): 2064\u20132069.","journal-title":"Kidney Int"},{"issue":"2","key":"BFjhh201227_CR36","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1161\/HYPERTENSIONAHA.107.100701","volume":"51","author":"E Pimenta","year":"2008","unstructured":"Pimenta E, Gaddam KK, Pratt-Ubunama MN, Nishizaka MK, Aban I, Oparil S et al. Relation of dietary salt and aldosterone to urinary protein excretion in subjects with resistant hypertension. Hypertension 2008; 51 (2): 339\u2013344.","journal-title":"Hypertension"},{"issue":"9","key":"BFjhh201227_CR37","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1210\/jc.2011-0354","volume":"96","author":"E Pimenta","year":"2011","unstructured":"Pimenta E, Gordon RD, Ahmed AH, Cowley D, Leano R, Marwick TH et al. Cardiac dimensions are largely determined by dietary salt in patients with primary aldosteronism: results of a case-control study. J Clin Endocrinol Metab 2011; 96 (9): 2813\u20132820.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"BFjhh201227_CR38","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1161\/HYPERTENSIONAHA.110.159277","volume":"56","author":"G du Cailar","year":"2010","unstructured":"du Cailar G, Fesler P, Ribstein J, Mimran A . Dietary sodium, aldosterone, and left ventricular mass changes during long-term inhibition of the renin-angiotensin system. Hypertension 2010; 56 (5): 865\u2013870.","journal-title":"Hypertension"},{"issue":"6","key":"BFjhh201227_CR39","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1161\/01.HYP.0000249902.09036.e7","volume":"48","author":"N Makhanova","year":"2006","unstructured":"Makhanova N, Sequeira-Lopez ML, Gomez RA, Kim HS, Smithies O . Disturbed homeostasis in sodium-restricted mice heterozygous and homozygous for aldosterone synthase gene disruption. Hypertension 2006; 48 (6): 1151\u20131159.","journal-title":"Hypertension"},{"issue":"1","key":"BFjhh201227_CR40","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0031-9384(93)90054-J","volume":"54","author":"MG Tordoff","year":"1993","unstructured":"Tordoff MG, Hughes RL, Pilchak DM . Different effects of three aldosterone treatments on plasma aldosterone and salt intake. Physiol Behav 1993; 54 (1): 129\u2013134.","journal-title":"Physiol Behav"},{"key":"BFjhh201227_CR41","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1152\/ajplegacy.1965.208.6.1281","volume":"208","author":"G Wolf","year":"1965","unstructured":"Wolf G . Effect of deoxycorticosterone on sodium appetite of intact and adrenalectomized rats. Am J Physiol 1965; 208: 1281\u20131285.","journal-title":"Am J Physiol"},{"issue":"5","key":"BFjhh201227_CR42","doi-asserted-by":"publisher","first-page":"H2241","DOI":"10.1152\/ajpheart.2001.281.5.H2241","volume":"281","author":"J Francis","year":"2001","unstructured":"Francis J, Weiss RM, Wei SG, Johnson AK, Beltz TG, Zimmerman K et al. Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure. Am J Physiol Heart Circ Physiol 2001; 281 (5): H2241\u2013H2251.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFjhh201227_CR43","doi-asserted-by":"crossref","unstructured":"Pimenta E, Gordon R, Ahmed A, Cowley D, Robson D, Kogovsek C et al. A-001 aldosterone excess stimulates salt appetite in patients with aldosterone producing adenoma. J Hypertens 29 (Suppl B): e1.","DOI":"10.1097\/01.hjh.0000407980.89443.13"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/jhh201227.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jhh201227","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jhh201227.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T20:13:26Z","timestamp":1647548006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jhh201227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,12]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["BFjhh201227"],"URL":"https:\/\/doi.org\/10.1038\/jhh.2012.27","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,12]]},"assertion":[{"value":"20 February 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}